Manual Manipulation and Ex Vivo Flexible Ureteroscopic Lithotripsy to Salvage Deceased Donor Kidneys With Renal Stones:a New Method byNCT06510101
Manual Manipulation and Ex Vivo Flexible Ureteroscopic Lithotripsy to Salvage Deceased Donor Kidneys With Renal Stones: A Case Series
An observational study of Manual Manipulation and Ex Vivo Flexible Ureteroscopic Lithotripsy to Salvage Deceased Donor Kidneys With Renal Stones:a New Method by, run by Yingxin FU.MD at 1 site in China.
Trial summary
we report the manual manipulation and Ex Vivo Flexible Ureteroscopic Lithotripsy to Salvage Deceased Donor Kidneys with Renal Stones,including nine cases,Renal transplantation was performed with the treated kidney after removing the stones, and the short-term postoperative outcomes were promising. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Manual Manipulation and Ex Vivo Flexible Ureteroscopic Lithotripsy to Salvage Deceased Donor Kidneys With Renal Stones:a New Method by
- How many people
- 9 participants
- Where
- 1 siteChina
- Study dates
- 1 Jan 2023to 30 Jul 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: patinet in our centor get a ranal transplantation with stones
Who may be able to join
- get renal transplantation donor kidney with stones
Who cannot join
- without renal stones the renal stones without Ex Vivo Flexible Ureteroscopic Lithotripsy
Trial locations and contacts
1 site in 1 country.
About this study
we report the manual manipulation and Ex Vivo Flexible Ureteroscopic Lithotripsy to Salvage Deceased Donor Kidneys with Renal Stones,including nine cases,Renal transplantation was performed with the treated kidney after removing the stones, and the short-term postoperative outcomes were promising. cases were thoroughly reported in this paper.
Read the detailed description
The presence of donor kidney stones may lead to ureteral obstruction after transplantation, affecting the recovery of postoperative renal function. Thus, donors with kidney stones are often considered marginal kidney donors and likely disqualified,Here we describe a series case of multiple kidney stones in a donor kidney treated with the combined application of fURS and holmium laser lithotripsy (HLL) before transplantation. Renal transplantation was performed with the treated kidney after removing the stones, and the short-term postoperative outcomes were promising. The case was thoroughly reported in this paper.
- Keywords
- organ donation;, kidney transplantation, flexible ureteroscopy;
What is being measured
The primary outcome is the main question the study is designed to answer.
eGFR
renal function
Measured: 3monthes after transplantation
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Jul 2024
- Study start1 Jan 2023
- Primary completion30 Jun 2024
- Study completion30 Jul 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Manual Manipulation and Ex Vivo Flexible Ureteroscopic Lithotripsy to Salvage Deceased Donor Kidneys With Renal Stones:a New Method byStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Retrospective
- Enrolment
- 9 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Yingxin FU.MD
- Sponsor type
- University, hospital or other
- Collaborators
- Shenzhen Third People's Hospital, The University of Hong Kong-Shenzhen Hospital
- Responsible party
- Sponsor-investigator, Yingxin FU.MD, Tianjin First Central Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06510101
- Sponsor's protocol ID
- MMEVFUL
- Status last verified
- Jul 2024
- First submitted
- 15 Jul 2024
- Last updated
- 19 Jul 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 Jul 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Manual Manipulation and Ex Vivo Flexible Ureteroscopic Lithotripsy to Salvage Deceased Donor Kidneys With Renal Stones: A Case Series
- ClinicalTrials.gov ID
- NCT06510101
- Acronym / sponsor ID
- MMEVFUL
- Keywords
- organ donation;, kidney transplantation, flexible ureteroscopy;
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 9 participants (estimated)
- Lead sponsor
- Yingxin FU.MDUniversity, hospital or other
- Collaborators
- Shenzhen Third People's Hospital, The University of Hong Kong-Shenzhen Hospital
- Study start
- 1 Jan 2023 (actual)
- Primary completion
- 30 Jun 2024 (actual)
- Study completion
- 30 Jul 2024 (estimated)
- First posted
- 19 Jul 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
we report the manual manipulation and Ex Vivo Flexible Ureteroscopic Lithotripsy to Salvage Deceased Donor Kidneys with Renal Stones,including nine cases,Renal transplantation was performed with the treated kidney after removing the stones, and the short-term postoperative outcomes were promising. cases were thoroughly reported in this paper.
Detailed description
The presence of donor kidney stones may lead to ureteral obstruction after transplantation, affecting the recovery of postoperative renal function. Thus, donors with kidney stones are often considered marginal kidney donors and likely disqualified,Here we describe a series case of multiple kidney stones in a donor kidney treated with the combined application of fURS and holmium laser lithotripsy (HLL) before transplantation. Renal transplantation was performed with the treated kidney after removing the stones, and the short-term postoperative outcomes were promising. The case was thoroughly reported in this paper.
Study design
- Observational model
- Case only
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- patinet in our centor get a ranal transplantation with stones
Key inclusion criteria (1 listed)
- get renal transplantation donor kidney with stones
Key exclusion criteria (1 listed)
- without renal stones the renal stones without Ex Vivo Flexible Ureteroscopic Lithotripsy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
eGFR
Time frame: 3monthes after transplantation
renal function
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Jul 2024.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Manual Manipulation and Ex Vivo Flexible Ureteroscopic Lithotripsy to Salvage Deceased Donor Kidneys With Renal Stones:a New Method by, run by Yingxin FU.MD at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 19 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
eGFR (time frame: 3monthes after transplantation). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jul 2024.